Get the Stockscreener App
0.00
100.00%
-23.50
After Hours:
23.49
23.49
+
Assertio Holdings Inc stock is traded at $0.00, with a volume of 0.
It is down -100.00% in the last 24 hours and down -100.00% over the past month.
Assertio Holdings Inc is a pharmaceutical company with comprehensive commercial capabilities offering differentiated products designed to address patients' needs. The group's focus is on supporting patients by marketing oncology, neurology, and pain management products.
See More
Previous Close:
$23.50
Open:
$0
24h Volume:
0
Relative Volume:
0.00
Market Cap:
$151.86M
Revenue:
$102.16M
Net Income/Loss:
$-35.69M
P/E Ratio:
0.00
EPS:
-5.7327
Net Cash Flow:
$-7.08M
1W Performance:
-100.00%
1M Performance:
-100.00%
6M Performance:
-100.00%
1Y Performance:
-100.00%
1-Day Range:
$0.00
$0.00
1-Week Range:
$0.00
$0.00
52-Week Range:
$0.00
$23.50
Assertio Holdings Inc Stock (ASRT) Company Profile
Name
Assertio Holdings Inc
Sector
Phone
(224) 419-7106
Address
100 S. SAUNDERS ROAD, LAKE FOREST, IL
Compare ASRT vs TAK, HLN, TEVA, ZTS, UTHR
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ASRT
Assertio Holdings Inc
|
0.00 | 151.86M | 102.16M | -35.69M | -7.08M | -5.7327 |
TAK
Takeda Pharmaceutical Co Adr
|
18.35 | 57.90B | 29.91B | 1.30B | 3.49B | 0.4056 |
HLN
Haleon Plc Adr
|
10.18 | 43.41B | 14.54B | 2.22B | 2.58B | 0.4871 |
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
38.10 | 42.89B | 17.53B | 1.58B | 444.18M | 1.3457 |
ZTS
Zoetis Inc
|
77.29 | 31.00B | 9.51B | 2.64B | 2.14B | 6.0361 |
UTHR
United Therapeutics Corp
|
518.53 | 22.35B | 3.17B | 1.29B | 1.01B | 27.09 |
Assertio Holdings Inc Stock (ASRT) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-09-26 | Downgrade | H.C. Wainwright | Buy → Neutral |
| Jul-26-24 | Initiated | Maxim Group | Buy |
| Jul-03-24 | Initiated | H.C. Wainwright | Buy |
| Nov-07-22 | Initiated | Lake Street | Buy |
| Nov-30-18 | Downgrade | Mizuho | Buy → Neutral |
Assertio Holdings Inc Stock (ASRT) Latest News
Assertio (ASRT) Quarterly Figures: EPS Does Not Reach the Reported Estimate in the Reported Period; After Results: The Stock Finishes Near Unchanged under the Current SnapshotEarnings Expansion Phase - vinanet.vn
Assertio Holdings (ASRT) Holds Steady at $23.50 as Traders Eye Key LevelsReversal Setup Alerts - Vinanet
Assertio Holdings (ASRT) Holds Steady at $23.5 as Traders Await DirectionIchimoku Kumo Break - dars.gov.et
Assertio Shareholder Alert - TMX Newsfile
Assertio Holdings (ASRT) Flat at $23.5 as Shares Trade in Established RangeMomentum Trade - vinanet.vn
Assertio Ongoing Deadline Alert - TMX Newsfile
Assertio Holdings (ASRT) Holds Steady at $23.50 as Shares Consolidate Within RangeVolume Breakout Ideas - vinanet.vn
Assertio Holdings, Inc. SEC Filing (Jul 31, 2026) - Stock Titan
Assertio Holdings (ASRT) Holds Steady at $23.5 as Stock Consolidates Near Key SupportAccumulation Line - vinanet.vn
Assertio Holdings (ASRT) Holds Steady at $23.50 Amid Key Technical LevelsSentiment Extreme - Vinanet
ASRT5746402 Bond Coupon Profile — Rate & Payments - TradingView
ASRT5746402 Bond Profile — Key Metrics - TradingView
Assertio Holdings (ASRT) Consolidates Near Key Levels, Poised for BreakoutJurik MA - vinanet.vn
Press Release: Assertio Provides Update on Garda Therapeutics Tender Process - Moomoo
Assertio Beats Investor Suit Over Drug, Merger Claims - Law360
Assertio Investors Fail to Advance Suit Over Spectrum Merger (1) - Bloomberg Law News
Assertio (ASRT) Small-Cap Growth Virtual Investor Conference Summary - Quartr
Assertio (ASRT) Proxy Filing Summary - Quartr
ASRT Stock Drops After-Hours On Discounted Buyout Deal — Retail Calls It A ‘Robbery’ - Stocktwits
Assertio (ASRT) Q2 2024 earnings summary - Quartr
Assertio Holdings (ASRT) Holds Steady Near Resistance as Trading Volume Remains SubduedSector ETF Flow - Bölüm Sonu Canavarı
Assertio Holdings (NASDAQ: ASRT) common stock struck from Nasdaq list - Stock Titan
Assertio Deadline Alert - TMX Newsfile
ASRT CLASS ACTION NOTICE: Kessler Topaz Meltzer & Check, LLP Reminds Assertio Holdings, Inc. (ASRT) Shareholders of Securities Fraud Class Action Lawsuit and Encourages Investors with Substantial Losses to Contact the Firm - TMX Newsfile
Zydus Lifesciences Completes Acquisition of Assertio Holdings - Machine Maker
[15-12G] Assertio Holdings, Inc. SEC Filing - Stock Titan
ASRT Q1 2026 Earnings: Steep EPS Miss Amid Silent Revenue DisclosuresLong-Term Guidance - dars.gov.et
Zydus’s acquisition of Assertio to bolster its specialty pharma presence in US market - Indian Pharma Post
Zydus Lifesciences Completes Acquisition of Assertio; Nasdaq Delisting Confirmed - Digital Health News
Assertio Holdings Inc (ASRT) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Assertio Holdings Inc (ASRT) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Assertio Holdings Inc (ASRT) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Zydus Acquires Assertio for Oncology Growth - Chemical Industry Digest
[EFFECT] Assertio Holdings, Inc. SEC Filing - Stock Titan
Assertio Holdings Inc (ASRT) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Zydus Completes USD 166.4 Million Acquisition of US-Based Assertio Holdings - Medical Dialogues
Key facts: Assertio appoints two directors; Nasdaq halt, delisting - TradingView
Zydus Lifesciences Completes Acquisition of US-Based Assertio Holdings - marketscreener.com
Zydus Lifesciences shares fall 2% as firm acquires US-based Assertio Holdings for $166 million - inkl
Assertio Holdings Completes Merger with Zydus Lifesciences; Shareholders Receive $23.50 Per Share in Cash 1 - Minichart
Assertio completes $23.50 per share merger with Zydus - Investing.com UK
Assertio (ASRT) director fully cashes out shares and options in Zydus $23.50-per-share merger - Stock Titan
Zydus buys Assertio (ASRT); EVP Schlessinger equity cashed out at $23.50 - Stock Titan
Assertio Holdings (ASRT) director exits as Zydus cash merger pays $23.50 - Stock Titan
Assertio (ASRT) director’s shares and options cashed out in $23.50 Zydus buyout - Stock Titan
Assertio (ASRT) COO exits stock, options and RSUs in $23.50-per-share cash merger - Stock Titan
Assertio (ASRT) CEO exits all shares and awards in $23.50-per-share cash merger - Stock Titan
Assertio (ASRT) director cashes out shares and options in Zydus merger - Stock Titan
Assertio (ASRT) director fully cashed out as $23.50-per-share merger closes - Stock Titan
CFO Ajay Patel exits Assertio (ASRT) stake in $23.50-per-share merger - Stock Titan
Zydus completes Assertio acquisition, notes repurchase rights triggered - scanx.trade
Assertio Holdings Inc Stock (ASRT) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.70%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):